Command Palette

Search for a command to run...

Clinical Trials · NCT00518115

Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

CompletedPhase 2Exenatide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
GlaxoSmithKline
Enrollment
361
Start date
Apr 2007
Locations
163 sites, 3 countries
Primary endpoint
Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 16
View Exenatide compound reference